Skip to main content

Peer Review reports

From: A phase Ib study of capecitabine and ziv-aflibercept followed by a phase II single-arm expansion cohort in chemotherapy refractory metastatic colorectal cancer

Original Submission
28 Feb 2019 Submitted Original manuscript
13 Apr 2019 Reviewed Reviewer Report - Alberto Zaniboni
22 May 2019 Reviewed Reviewer Report - John Bridgewater
10 Sep 2019 Author responded Author comments - John Strickler
Resubmission - Version 2
10 Sep 2019 Submitted Manuscript version 2
14 Sep 2019 Reviewed Reviewer Report - Alberto Zaniboni
1 Oct 2019 Author responded Author comments - John Strickler
Resubmission - Version 3
1 Oct 2019 Submitted Manuscript version 3
Publishing
2 Oct 2019 Editorially accepted
1 Nov 2019 Article published 10.1186/s12885-019-6234-8

You can find further information about peer review here.

Back to article page